Beth Darnall
Beth Darnall
Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult MSD) and, by courtesy, of Psychiatry and Behavioral Sciences (General Psychiatry & Psychology (Adult)) at the Stanford University Medical Center
PhD Training:University of Colorado at Boulder (2002) CO
Fellowship:The Johns Hopkins University (2004) MD
Internship:Southern Arizona VA Healthcare System (2002) AZ
MA, University of Colorado at Boulder, Clinical Psychology (1998)
PhD, University of Colorado at Boulder, Clinical Psychology (2002)
Post-Doc, The Johns Hopkins University School of Medicine, Rehabilitation Psychology (2004)
Beth Darnall, PhD, is Associate Professor in the Department of Anesthesiology, Perioperative and Pain Medicine, and by courtesy, Psychiatry and Behavioral Sciences. She is a pain psychologist and scientist. Her primary interests are in developing and investigating brief, low-cost, low-burden, accessible treatments that empower patients and reduce acute and chronic pain and associated burdens. Her ultimate goal is to rapidly scale access to evidence-based behavioral medicine for acute and chronic pain.
Dr. Darnall is principal investigator with $14M in current NIH and PCORI-funded clinical trials that broadly investigate behavioral pain medicine and self-management strategies and voluntary patient-centered prescription opioid reduction. Her single-session, skills-based behavioral medicine class (“Empowered Relief”) is the subject of NIH clinical trials and McGill researchers are studying its efficacy in primary care clinics (https://empoweredrelief.com). Her digital perioperative intervention (“My Surgical Success”) is being studied at Stanford Hospital and the Cleveland Clinic, and initial studies show the no-therapist e-intervention reduces opioid requirement after breast cancer surgery. Her research specifically investigates digital and in-person behavioral pain medicine treatments as opioid-sparing strategies after surgery and in for outpatient opioid tapering. The broad goal of this collective line of research is to dismantle barriers to effective behavioral medicine for pain.
She is principal investigator for the EMPOWER study, a 4-state pragmatic randomized controlled clinical trial that is investigating how to best help physicians and patients successfully and voluntarily reduce long term opioid use and chronic pain using patient-centered methods. The project is funded by the Patient Centered Outcomes Research Institute (PCORI) and involves 1,365 patients taking long term opioids; the goal is to reduce patient health risks without increasing pain. This research involves a 3-arm RCT comparative effectiveness trial of two evidence-based behavioral treatments, cognitive behavioral therapy for pain and chronic pain self-management, within the context of patient-centered opioid tapering. This research builds on her team's first report on "Patient-Centered Prescription Opioid Tapering in Community Outpatients with Chronic Pain" (Darnall et al, JAMA Int Med, 2018). Learn more about the EMPOWER study at https://empower.stanford.edu/
https://bethdarnall.com/
Twitter: @bethdarnall
https://empoweredrelief.com
Dr. Darnall is principal investigator with $14M in current NIH and PCORI-funded clinical trials that broadly investigate behavioral pain medicine and self-management strategies and voluntary patient-centered prescription opioid reduction. Her single-session, skills-based behavioral medicine class (“Empowered Relief”) is the subject of NIH clinical trials and McGill researchers are studying its efficacy in primary care clinics (https://empoweredrelief.com). Her digital perioperative intervention (“My Surgical Success”) is being studied at Stanford Hospital and the Cleveland Clinic, and initial studies show the no-therapist e-intervention reduces opioid requirement after breast cancer surgery. Her research specifically investigates digital and in-person behavioral pain medicine treatments as opioid-sparing strategies after surgery and in for outpatient opioid tapering. The broad goal of this collective line of research is to dismantle barriers to effective behavioral medicine for pain.
She is principal investigator for the EMPOWER study, a 4-state pragmatic randomized controlled clinical trial that is investigating how to best help physicians and patients successfully and voluntarily reduce long term opioid use and chronic pain using patient-centered methods. The project is funded by the Patient Centered Outcomes Research Institute (PCORI) and involves 1,365 patients taking long term opioids; the goal is to reduce patient health risks without increasing pain. This research involves a 3-arm RCT comparative effectiveness trial of two evidence-based behavioral treatments, cognitive behavioral therapy for pain and chronic pain self-management, within the context of patient-centered opioid tapering. This research builds on her team's first report on "Patient-Centered Prescription Opioid Tapering in Community Outpatients with Chronic Pain" (Darnall et al, JAMA Int Med, 2018). Learn more about the EMPOWER study at https://empower.stanford.edu/
https://bethdarnall.com/
Twitter: @bethdarnall
https://empoweredrelief.com
